Zymeworks (ZYME) Retained Earnings (2021 - 2026)
Zymeworks' (ZYME) quarterly Retained Earnings came in at -$6.6 million in Q1 2026, down 2.48% year-on-year from -$6.7 million in Q1 2025, and down 7.99% quarter-over-quarter from -$6.1 million in Q4 2025.
Zymeworks (ZYME) Retained Earnings (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Retained Earnings across 6 years of filings, most recently posting -$6.6 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$6.6 million, down 2.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.6 million (down 2.48% YoY), and the FY2025 annual result was -$6.1 million, up 99.27% from the prior year.
- Retained Earnings came in at -$6.6 million for Q1 2026 at Zymeworks, down from -$6.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$6.0 million in Q3 2025 to a low of -$850.7 million in Q2 2025.
- The 5-year median for Retained Earnings is -$7.9 million (2024), against an average of -$344.4 million.
- Peak annual rise in Retained Earnings reached 99.27% in 2025, while the deepest fall reached 10662.32% in 2025.
- Zymeworks' Retained Earnings stood at -$6.7 million in 2022, then slumped by 10073.25% to -$677.4 million in 2023, then retreated by 22.57% to -$830.3 million in 2024, then jumped by 99.27% to -$6.1 million in 2025, then decreased by 7.99% to -$6.6 million in 2026.
- The last three Retained Earnings figures came in at -$6.6 million (Q1 2026), -$6.1 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -6.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.57 Mn |
| Dec 31, 2025 | -6.08 Mn |
| Sep 30, 2025 | -6.05 Mn |
| Jun 30, 2025 | -850.65 Mn |
| Mar 31, 2025 | -6.41 Mn |
| Dec 31, 2024 | -830.34 Mn |
| Sep 30, 2024 | -797.83 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Mar 31, 2024 | -709.09 Mn |
| Dec 31, 2023 | -677.44 Mn |
| Sep 30, 2023 | -662.96 Mn |
| Jun 30, 2023 | -7.81 Mn |
| Mar 31, 2023 | -583.12 Mn |
| Dec 31, 2022 | -6.66 Mn |
| Sep 30, 2022 | -6.66 Mn |
| Dec 31, 2021 | -683.10 Mn |